COSCIENS Biopharma Inc.
CSCI.TO
TSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -8.67% | -32.16% | -16.07% | -18.03% | -28.08% |
| Total Receivables | -42.33% | 49.70% | -24.77% | 22.63% | 48.71% |
| Inventory | -3.40% | -25.82% | -8.77% | -18.60% | 8.22% |
| Prepaid Expenses | -27.87% | 34.25% | -16.35% | -12.60% | 48,525.00% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -13.24% | -23.60% | 18.46% | -24.14% | -3.33% |
| Total Current Assets | -16.17% | -18.92% | -15.12% | -15.02% | -15.02% |
|
|
|||||
| Total Current Assets | -16.17% | -18.92% | -15.12% | -15.02% | -15.02% |
| Net Property, Plant & Equipment | -9.44% | 2.48% | -2.80% | -7.12% | 2.68% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -100.00% | -45.82% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | 3.13% | 4.07% | -93.64% | -3.44% |
| Total Assets | -13.42% | -11.51% | -11.20% | -19.87% | -12.54% |
|
|
|||||
| Total Accounts Payable | -32.90% | -46.25% | 18.65% | 0.46% | -33.17% |
| Total Accrued Expenses | -39.83% | -19.39% | -19.74% | -7.38% | 13.48% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.44% | -17.39% | -6.64% | -33.09% | -0.49% |
| Total Finance Division Other Current Liabilities | -20.96% | 12.36% | -5.80% | -22.56% | -23.12% |
| Total Other Current Liabilities | -20.96% | 12.36% | -5.80% | -22.56% | -23.12% |
| Total Current Liabilities | -28.59% | -20.98% | -2.26% | -11.57% | -17.49% |
|
|
|||||
| Total Current Liabilities | -28.59% | -20.98% | -2.26% | -11.57% | -17.49% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -4.39% | 3.85% | -3.24% | 68.37% | -5.39% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 0.02% | 7.26% | -5.40% | -12.03% | 13.74% |
| Total Liabilities | -8.22% | -2.55% | -4.16% | -7.77% | -0.26% |
|
|
|||||
| Common Stock & APIC | 0.10% | 0.43% | 0.08% | 0.44% | 1.75% |
| Retained Earnings | -10.57% | -17.55% | -21.02% | -134.78% | -436.46% |
| Treasury Stock & Other | -12.65% | -24.91% | -17.56% | 0.04% | 3.42% |
| Total Common Equity | -28.42% | -30.04% | -22.92% | -34.24% | -23.69% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -28.42% | -30.04% | -22.92% | -34.24% | -23.69% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -28.42% | -30.04% | -22.92% | -34.24% | -23.69% |
|
|
|||||